Skip to content

A study on the endometrial molecular mechanism of reproductive outcome heterogeneity after EIN/ECa conservation treatment based on multi-omics technology

A study on the endometrial molecular mechanism of reproductive outcome heterogeneity after EIN/ECa conservation treatment based on multi-omics technology

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125179
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial atypical hyperplasia, endometrial cancer, repeated implantation failures

Interventions

Control group:N/A
Repeated implantation failures group:N/A
Atypical hyperplasia of endometrium/endometrial carcinoma group:N/A

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 38 Years

Inclusion criteria

Inclusion criteria: 1. Age range of 20-38 years old, normal BMI range; 2. Normal ovarian reserve, amh>1.5; 3. First or second resuscitation transplant; 4.On the day of transplantation, the thickness of the endometrium should be greater than 8mm.

Exclusion criteria

Exclusion criteria: 1. No endometrial lesions; 2. No adenomyosis or endometriosis; 3. No intrauterine adhesions; 4. No recurrence of implant failure or recurrent miscarriage; 5. No medical disease (diabetes, insulin resistance, thyroid abnormality, hypertension, immune disease).

Design outcomes

Primary

MeasureTime frame
RNA seq detection and analysis of differential gene expression of FGF1/PIM1/TLR4 in samples from different groups;Identification of Specific Cell Groups and Gene Expression Differences by Single Cell RNA Sequencing;Multi factor detection of Th1/2, VEGF/IL-6 and other immune factors in different groups using liquid phase protein chip;Proteomic and metabolomic mass spectrometry detection of differential expression of proteins, lipids, amino acid metabolites, etc;

Countries

China

Contacts

Public ContactTao Tao

Peking Union Medical College Hospital

theressatao@163.com+86 134 8866 7286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026